在患有表皮生长因子受体突变的非小细胞肺癌中,骨质芽细胞骨反应用 osimertinib 治疗
Kensuke Kanaoka1, Hiromitsu Sumikawa2, Shunsuke Oyamada3
1Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, 1180 Nagasone-Cho, Kitaku, Sakai City, Osaka, 591-8555, Japan. kanaoka.k.612@gmail.com.
BMC cancer
|September 6, 2023
概括
骨质细胞骨反应 (OBR) 在EGFR突变非小细胞肺癌患者中常见,这些患者接受了osimertinib治疗. OBR不是疾病进展,可以预测更长的骨相关无事件生存期.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨质质细胞骨反应 (OBR) 表示治疗后骨密度增加或新的硬化病变,通常被误认为是疾病进展.
- 在接受 osimertinib 的 EGFR 突变非小细胞肺癌 (NSCLC) 患者中调查 OBR 患病率和临床结果至关重要.
结论:
- 在EGFR突变NSCLC患者中经常出现OBR,这些患者在osimertinib上发生骨转移.
- 不应将OBR误诊为疾病进展.
- 仔细考虑OBR对于治疗决策至关重要.
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K


